ACACA and metabolic disease: The inhibition or knockout of ACC1 and ACC2 has a positive effect for alleviating liver fat deposition, which promotes ACC to be an attractive target for metabolic diseases in mammals over the past few decades [1,2,3,4,5,6,7,8].